LABORATORIOS FARMACEUT./ ES0157261019 /
| 2024-09-10 8:05:57 AM | Chg. +0.85 | Volume | Bid9:41:12 AM | Ask9:41:12 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 81.95EUR | +1.05% | 0 Turnover: 0.00 |
79.30Bid Size: 150 | 80.45Ask Size: 150 | 4.33 bill.EUR | 1.61% | 25.08 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.20 EUR | -14.21% |
| EPS Diluted: | - EUR | -14.21% |
| Revenues per Share: | 15.36 EUR | 1.44% |
| Book Value per Share: | 9.99 EUR | 3.73% |
| Cash Flow per Share: | 2.10 EUR | -52.34% |
| Dividend per Share: | 1.29 EUR | 35.39% |
| Total | in th. | |
| Revenues: | 829,509.00 EUR | 1.44% |
| Net Income: | 170,335.00 EUR | -14.69% |
| Operating Cash Flow: | 113,247.00 EUR | - |
| Cash and Cash Equivalents: | 25,322.00 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 25.08 | 18.81 |
| P/S Ratio: | 5.23 | 3.92 |
| P/BV ratio: | 8.04 | 6.03 |
| P/CF Ratio: | 38.28 | 28.71 |
| PEG: | -1.76 | -1.32 |
| Earnings Yield: | 3.99% | 5.32% |
| Dividend Yield: | 1.61% | 2.15% |
| Market Capitalization | ||
| Market Capitalization: | 4.33 bill. EUR | 3.25 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 2.05 mill. EUR | 1.54 mill. EUR |
| Shares Outstanding: | 54.02 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 26.55% |
| Net Profit Margin: | 20.53% |
| Return on Equity: | 31.58% |
| Return on Assets: | 21.30% |
Financial Strength
| Liquidity I / Cash Ratio: | 12.67% |
| Liquidity II / Quick Ratio: | 84.38% |
| Liquidity III / Current Ratio: | 254.87% |
| Debt / Equity Ratio: | 48.30% |
| Dynam. Debt / Equity Ratio: | 230.03% |
Efficiency
| Employees: | 2,111 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 392,946.00 EUR |
| Net Income / Employee: | 80,689.25 EUR |
| Total Assets / Employee: | 378,912.36 EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
